CTNNB1 S45F Mutation Predicts Poor Efficacy of Meloxicam Treatment for Desmoid Tumors: A Pilot Study

‘Difficult to diagnose’ desmoid tumours: a potential role forCTNNB1mutational analysis

(2015) Chiara Colombo et al.   HISTOPATHOLOGY

Nuclear expression of β-catenin predicts the efficacy of meloxicam treatment for patients with sporadic desmoid tumors

(2014) Shunsuke Hamada et al.   TUMOR BIOLOGY

Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group

(2013) A. Gronchi et al.   ANNALS OF ONCOLOGY

CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence

(2013) Chiara Colombo et al.   CANCER

 -Catenin Mutation Status and Outcomes in Sporadic Desmoid Tumors

(2013) J. T. Mullen et al.   ONCOLOGIST

The treatment of desmoid tumors: a stepwise clinical approach

(2012) S. Bonvalot et al.   ANNALS OF ONCOLOGY

β-Catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis

(2012) Sebastian Huss et al.   HISTOPATHOLOGY

Is It Possible to Identify Clinically Useful Prognostic Groups for Patients With Desmoid Tumors?

(2012) Yoshihiro Nishida et al.   JOURNAL OF CLINICAL ONCOLOGY

CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics

(2012) Sophie Le Guellec et al.   MODERN PATHOLOGY

Transition of Treatment for Patients with Extra-Abdominal Desmoid Tumors: Nagoya University Modality

(2012) Yoshihiro Nishida et al.   Cancers

Update on desmoid tumors

(2011) C. Escobar et al.   ANNALS OF ONCOLOGY

High frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management

(2010) J Dômont et al.   BRITISH JOURNAL OF CANCER

Primary or recurring extra-abdominal desmoid fibromatosis: Assessment of treatment by observation only

(2010) O. Barbier et al.   Orthopaedics & Traumatology-Surgery & Research

Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment

(2009) Marco Fiore et al.   ANNALS OF SURGICAL ONCOLOGY

Cyclooxygenase-2 Overexpression Predicts Poor Survival in Patients with High-grade Extremity Osteosarcoma: A Pilot Study

(2009) Hiroshi Urakawa et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Efficiency evaluation of a DNA extraction and purification protocol on archival formalin-fixed and paraffin-embedded tissue

(2009) A. Farrugia et al.   FORENSIC SCIENCE INTERNATIONAL

Successful Treatment With Meloxicam, a Cyclooxygenase-2 Inhibitor, of Patients With Extra-Abdominal Desmoid Tumors: A Pilot Study

(2009) Yoshihiro Nishida et al.   JOURNAL OF CLINICAL ONCOLOGY

Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors

(2008) Alexander J.F. Lazar et al.   AMERICAN JOURNAL OF PATHOLOGY

Surgical treatment for local control of extremity and trunk desmoid tumors

(2008) Yoji Shido et al.   ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY